Clinical Trial Update: Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial assessing letrozole for cancer prevention in postmenopausal women after 4–6 years of hormone therapy for HR-positive, lymph node–positive, early-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-01-29